Clinical Trial Update: China Atrial Fibrillation With Complex Metabolic Disorder Cohort Study (CAME Cohort)

View source ↗

Summary

This ClinicalTrials.gov entry updates the CAME Cohort study on atrial fibrillation associated with complex metabolic disorders in China, which is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Metabolic Syndrome

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Atrial Fibrillation (AF), Metabolic Disorders | Status: NOT_YET_RECRUITING